Search results (231)
« Back to News & EventsOxford researchers hunt for hidden protein clues to prevent prostate cancer
10 June 2026
A major new research programme, led by Professor Ruth Travis and Dr Karl Smith-Byrne and funded by Cancer Research UK, aims to uncover the biological causes of prostate cancer and identify ways to prevent the disease.
First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford
9 June 2026
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
OxCODE Associate Director Professor Ellie Barnes named BRC Oxford Deputy Director
4 June 2026
Professor Ellie Barnes has been appointed as Deputy Director of the NIHR Biomedical Research Centre: Oxford.
World’s largest study of women’s health marks 30 years of pioneering research
7 May 2026
The Million Women Study has generated landmark findings on HRT and cancer risk, as well as other aspects of women's health
Funding for research to investigate how certain cancers turn aggressive
28 April 2026
Dr Srinivasa Rao and Dr Beatriz Gamez Molina receive a Cancer Research UK Early Detection and Diagnosis Primer award to improve early detection and prevention of progression in prostate cancer and multiple myeloma.
New Oxford-led study set to evaluate multi-cancer tests in GP practices for earlier diagnosis
14 April 2026
Clinical Associate Professor Brian Nicholson has received £3.6 million to explore whether multi-cancer tests can help GPs identify cancer earlier in people with non-specific symptoms.
Funding for molecular tools to more precisely diagnose prostate cancer
26 March 2026
Dr Pengfei Li and Dr Jonathan Wojciechowski receive a Cancer Research UK Early Detection and Diagnosis Primer Award to analyse modifications to PSA for early detection and phenotyping of prostate cancer.
Blood test could improve survival of childhood cancer in Africa
19 March 2026
A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.
Early-phase study demonstrates safety and immune response of therapeutic HPV vaccine
24 February 2026
An early-phase clinical trial led by Associate Professor Karin Hellner has reported results evaluating a new therapeutic vaccine designed to help the body clear high-risk human papillomavirus (HPV) infection in women with low-grade cervical lesions.
Is now the time to rethink risk thresholds in cancer referral guidelines?
9 December 2025
A new editorial published in the British Journal of General Practice by Associate Professor Brian Nicholson examines how recent research presents an opportunity to refresh how risk thresholds are applied in national primary care cancer referral guidelines.
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 November 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
19 November 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
PODCAST: Could vaccinations stop people from getting cancer?
12 November 2025
Professor Sarah Blagden discusses novel research approaches to cancer prevention on the Oxford Sparks podcast.
Professor Sarah Blagden to star in New Landmark Channel 4 Documentary Series 'Cancer Detectives: Finding the Cures'
16 October 2025
Channel 4 today announces 'Cancer Detectives: Finding the Cures', an observational documentary series that will explore the pioneering research that could transform the future of cancer detection, treatment and prevention.
PSA testing patterns in England raise concerns about overtesting
8 October 2025
A study of 10 million men finds many are having prostate cancer tests more frequently than recommended, with significant variations in PSA testing across England, raising concerns about overtesting.
New study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms
10 September 2025
A major UK study, led by OxCODE researchers has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue.
Platelets shown to store DNA in study that could transform cancer screening
15 August 2025
Oxford-led study uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
Advance Your Research with the SCAN Pathway
20 July 2025
The SCAN pathway offers a unique opportunity to access one of the UK’s most comprehensive research infrastructures for non-specific cancer symptoms.
OxCODE travel awards 2025
25 June 2025
Congratulations to Zinaida Dedeic, Joshua Fieggen, Ella Mi, Shizhe Xu, Yuhan Zheng and Noushin Zibandeh who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.
New vaccines that aim to prevent cancer: Starting the conversation
11 June 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.